Position
Squarepoint Ops LLC in Relay Therapeutics, Inc.
Back to the book · All holders of RLAY
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $140.4K$8.46 → $9.95
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 94.2K | $797K | — | — | — | 0.0% |
| Q1 2026 | 180.3K | $1.79M | $9.95 | $140.4K | $856.6K | 0.0% |